SCIENTIFIC PROGRAM
| THURSDAY, JUNE 25, 2026 | ||
| 08:00 – 09:00 | Registration | |
| 09:00 – 09:15 | Opening Ceremony | |
| 09:15 – 09:45 | Opening Lecture Chairs: Michael Schirmer, Andreas Altenburg, Ahmet Gül |
|
| Hulusi Behçet and His Legacy | Ahmet Gül | |
| 09:45 – 11:25 | Basic Science: What is New? Chairs: Güher Saruhan Direskeneli, Jan van Laar, Graham Wallace |
|
| 09:45 – 10:05 | HLA and Behçet Disease – What is New? | Johannes Nowatzky |
| 10:05 – 10:25 | Single Cell Studies in Behçet Disease | Amr Sawalha |
| 10:25 – 10:45 | Update on the Animal Models | Seonghyang Sohn |
| 10:45 – 11:05 | Overview and Discussion | Graham Wallace |
| 11:05 – 11:25 | Oral Presentations | |
| 11:05 – 11:15 | CD177⁺ neutrophils promote endothelial senescence via Histone3.1-enriched NETs in Behçet’s Disease | Wenjie Zheng |
| 11:15 – 11:25 | Sustained Cytotoxic T Cell–Dendritic Cell Crosstalk Underlies Chronic Inflammation in Behçet’s Disease | Seunghee Hong |
| 11:25 – 11:45 | COFFEE BREAK | |
| 11:45 – 12:35 | Conference Chairs: Eun-So Lee, Lale Öcal |
|
| 11:45 – 12:05 | Behçet Disease Around the Globe | Farhad Shahram |
| 12:05 – 12:25 | Changes in the Disease Phenotpe | Yohei Kirino |
| 12:25 – 12:35 | Discussion | |
| 12:35 – 13:30 | LUNCH BREAK AND POSTER VIEWING | |
| 13:30 – 15:40 | Mucocutaneous Involvement Chairs: Dongsik Bang, Tülin Ergun, Ayşe Boyvat |
|
| 13:30 – 13:50 | Bipolar Aphthosis | Erkan Alpsoy |
| 13:50 – 14:10 | Non-Aphthous Mucocutaneous Findings | Doyoung Kim |
| 14:10 – 14:30 | Pathergy Phenomenon | Ahmet Gül |
| 14:30 – 14:50 | What is the Ideal Treatment for Individual Patient? | Tülin Ergun |
| 14:50 – 15:10 | How to Monitor Oral Disease Activity? | Gonca Mumcu |
| 15:10 – 15:20 | Discussion | |
| 15:20 – 15:40 | Oral Presentations | |
| 15:20 – 15:30 | Multicenter Validation of the 23-Valent Polysaccharide Pneumococcal Vaccine-Induced Skin Pathergy Test in Behçet’s Disease | Rabia Deniz |
| 15:30 – 15:40 | Behcet disease in pediatric versus adult patients (Updates from Iran BD Registry) | Farhad Shahram |
| 15:40 – 16:00 | COFFEE BREAK | |
| 16:00 – 17:10 | Pediatric Behçet Disease and Differential Diagnosis Chairs: Nuray Aktay Ayaz, Özgür Kasapçopur |
|
| 16:00 – 16:20 | Pediatric Behçet Disease: Summary of the Task Force Works | Seza Özen |
| 16:20 – 16:40 | Monogenic Mimics of Behçet Disease | Fatma Dedeoğlu (Online) |
| 16:40 – 17:00 | Trisomy 8, Myelodysplastic Syndrome and TRIAD | Kalpana Manthiram (Online) |
| 17:00 – 17:10 | Discussion | |
| 17:10 – 18:30 | Clinical Trial Design – Round Table Chairs: Gülen Hatemi, David Saadoun |
|
| Challenges and Pitfalls of Clinical Trials | Gülen Hatemi | |
| Problems in Study Design for Individual Manifestations, Damage Assessment and Basic Studies (Round Table) | ||
| Vascular Involvement | David Saadoun | |
| Ocular Involvement | Bahram Bodaghi | |
| Gastrointestinal Involvement | İbrahim Hatemi | |
| Mucocutaneous Involvement | Farida Fortune | |
| Musculoskeletal Involvement | Ina Kötter | |
| Assessment of Damage | Luca Cantarini | |
| Basic Research | Yeşim Özgüler | |
| Wrap-Up | Gülen Hatemi | |
| 18:30 – 20:30 | OPENİNG COCKTAIL | |
| 20:30 – 23:00 | SPEAKERS DINNER | |
| FRIDAY, JUNE 26, 2026 | ||
| 08:00 – 09:00 | Study Group Meetings | |
| 09:00 – 09:30 | Colin Barnes Conference Chairs: Vedat Hamuryudan, Farida Fortune |
|
| Colin Barnes and His Contributions to the Research in Behçet Disease | Hasan Yazıcı | |
| 09:30 – 10:40 | Criteria for Classification and Diagnosis Chairs: Hasan Yazıcı, Michael Schirmer |
|
| 09:30 – 09:50 | Pitfalls of the Criteria in the Diagnostic Algorithms | Christos Zoubulis |
| 09:50 – 10:10 | HLA-B51 and Other Tools in the Assessment of Disease Activity, Severity and Prognosis |
Mitsuhiro Takeno |
| 10:10 – 10:30 | How to Improve the Criteria for Neuro-Behçet Disease? | Aksel Siva |
| 10:30 – 10:40 | Discussion | |
| 10:40 – 11:00 | COFFEE BREAK | |
| 11:00 – 12:00 | Ocular Involvement – Differential Diagnosis and Monitoring Masaki Takeuchi Conference Chair: Yohei Kirino, Pınar Çakar Özdal |
|
| 11:00 – 11:10 | Introduction | Yohei Kirino |
| 11:10 – 11:40 | Distinctive Features of Behçet Disease Uveitis and Differential Diagnosis | İlknur Tuğal Tutkun |
| 11:40 – 12:00 | Oral Presentations | |
| 11:40 – 11:50 | Concordance of Clinical Phenotypes, HLA-B51, and ERAP-1 Variations Among First-Degree Relatives with Behçet Syndrome | Sinem Nihal Esatoğlu |
| 11:50 – 12:00 | Vδ2 T-cell–driven B-cell dysregulation and autoantibody production in Behçet’s Syndrome | Sahar Mohammed |
| 12:00 – 13:00 | LUNCH BREAK AND POSTER VIEWING | |
| 13:00 – 15:00 | Ocular – Disease Monitoring and Treatment Chairs: İlknur Tuğal Tutkun, İzzet Fresko |
|
| 13:00 – 13:20 | Monitoring Tools for Non-Ophthalmologists | Hilal Eser Öztürk |
| 13:20 – 13:45 | Anti-TNF and Alternative Treatments in Behçet Disease Uveitis | Didar Uçar |
| 13:45 – 14:15 | How to Define Remission and Discontinue Treatment | Pınar Çakar Özdal |
| 14:15 – 14:30 | Discussion | Panel |
| 14:30 – 15:00 | Oral Presentations | |
| 14:30 – 14:40 | Clinical Efficacy of Weekly Adalimumab in Behçet Uveitis: A Retrospective Analysis | Mustafa Asım Erol |
| 14:40 – 14:50 | First-Line Anti-TNF Treatment in Behçet’s Uveitis | Zeynep Yüksel |
| 14:50 – 15:00 | Severe Visual Impairment In Behçet Syndrome In Time: A Comparison Of Four Time Periods | Mustafa Erdoğan |
| 15:00 – 15:20 | COFFEE BREAK | |
| 15:20 – 15:50 | Gastrointestinal Involvement – Round Table | |
| Intestinal Inflammation as a Model of Complex Disease | Aykut Ferhat Çelik, Ahmet Gül | |
| 15:50 – 17:10 | Differential Diagnosis Chairs: Murat Törüner, Aykut Ferhat Çelik |
|
| 15:50 – 16:10 | Differential Diagnosis with IBD (Turkish experience) | Aykut Ferhat Çelik |
| 16:10 – 16:30 | Differential Diagnosis with IBD (Korean experience) | Jae Hee Cheon (Online) |
| 16:30 – 16:40 | Discussion | |
| 16:40 – 17:10 | Oral Presentations | |
| 16:40 – 16:50 | Exploration of biomarkers and immune mechanisms in intestinal Behçet’s Syndrome based on whole blood transcriptomic features | Xin Yu |
| 16:50 – 17:00 | Prediction for the development of Intestinal Behçet’s disease based on extraintestinal factors | Mitsuhiro Takeno |
| 17:00 – 17:10 | Efficacy and safety of JAK inhibitors in Behçet syndrome: Systematic literature review | Sinem Nihal Esatoglu |
| 17:10 – 17:30 | COFFEE BREAK | |
| 17:30 – 18:45 | Inflammatory Pathways and Targeted Treatments Chairs: Murat İnanç, Emire Seyahi |
|
| 17:30 – 17:45 | Biologic Treatments in Spondyloarthritis | Abdurrahman Tufan |
| 17:45 – 18:00 | Colchicine Resistance and Biologic Treatments in FMF and Other SAIDs | Serdal Uğurlu |
| 18:00 – 18:15 | Biologic Treatment Targets in Non-Infectious Uveitis | Nilüfer Yalçındağ |
| 18:15 – 18:30 | Targeted Treatments in Inflammatory Bowel Disease | Murat Törüner |
| 18:30 – 18:45 | How to Extrapolate to BD: Targeted and Personalized Treatment Strategies | Yohei Kirino |
| 18:45 – 18:50 | Wrap-Up and Discussion | |
| 18:50 – 19:50 | ISBD Meeting | |
| 19:50 – 22:30 | GALA DINNER | |
| SATURDAY, JUNE 27, 2026 | ||
| 08:00 – 09:00 | Study Group Meetings | |
| 09:00 – 10:40 | Cardiovascular Involvement Chairs: David Saadoun, Melike Melikoğlu |
|
| 09:00 – 09:20 | Pulmonary Involvement – More Than Thought | Fatma Alibaz |
| 09:20 – 09:40 | Coronary and Cardiac Involvement | Emire Seyahi |
| 09:40 – 10:00 | Is Behçet Disease a Thromboinflammatory Venulitis? | Giacomo Emmi |
| 10:00 – 10:20 | Screening of the Patients for CV Involvement | Panel |
| 10:20 – 10:30 | Discussion | |
| 10:30 – 10:40 | Oral Presentations | |
| 10:30 – 10:40 | Clinical course and radiological outcomes of pulmonary artery thrombosis in Behçet’s disease: a comparative study with non-Behçet pulmonary thrombosis | Aida Shikhaliyeva |
| 10:40 – 11:00 | COFFEE BREAK | |
| 11:00 – 12:00 | Neurologic – Differential Diagnosis and Monitoring Chairs: Gülşen Akman Demir, Aksel Siva |
|
| 11:00 – 11:20 | Atypical Presentations of Neuro-BD | Tuncay Gündüz |
| 11:20 – 11:40 | How to Monitor and Treat Neuro-BD? | Uğur Uygunoğlu |
| 11:40 – 11:50 | Discussion | |
| 11:50 – 12:00 | Oral Presentation | |
| 11:50 – 12:00 | Development of algorithms for treatment of neuro-Behçet’s disease | Shunsei Hirohata |
| 12:00 – 13:00 | LUNCH BREAK AND POSTER VIEWING | |
| 13:00 – 13:40 | Oral Presentations | |
| 13:00 – 13:10 | Clinical, Radiological, and Prognostic Characteristics of Neuro-Behçet’s Syndrome: Analysis of 507 Patients | Nursena Erener |
| 13:10 – 13:20 | Postthrombotic Vascular Remodeling in Behçet Syndrome | Tümay Ak |
| 13:20 – 13:30 | Chronic Thromboembolic Pulmonary Hypertension Secondary to Pulmonary Artery Involvement of Behçet’s Syndrome | Ilker Ihtiyaroğlu |
| 13:30 – 13:40 | Phenotype-Specific Immune Signatures in Behçet’s Disease: A Transcriptomic and Cytokine Based Approach | Rabia Deniz |
| 13:40 – 14:45 | Recent Recommendations for Management Chairs: Sabahattin Yurdakul, Giacomo Emmi |
|
| 13:40 – 14:05 | Updated EULAR Recommendations | Gülen Hatemi |
| 14:05 – 14:30 | Other Recommendations for the Management of BD | Haner Direskeneli |
| 14:30 – 14:35 | Discussion | |
| 14:35 – 14:50 | COFFEE BREAK | |
| 14:50 – 15:45 | Personalized Medicine and Expectations for the Future Chairs: Gonca Mumcu, Farida Fortune |
|
| 14:50 – 15:10 | Patient Perspective | Rosaria Talarico |
| 15:10 – 15:30 | Drug-Free Remission: A Realistic Target? | Nikolaos Kougkas |
| 15:30 – 15:45 | International Collaborations | Alessandra Bettiol (Online) |
| 15:45 – 16:00 | Wrap-Up and Discussion | |
| 16:00 | Adjourn | |
